Chemed Pre-Tax Profit Margin 2010-2024 | CHE

Current and historical pre-tax profit margin for Chemed (CHE) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Chemed pre-tax profit margin for the three months ending March 31, 2024 was .
Chemed Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-03-31 $2.29B $0.36B 15.82%
2023-12-31 $2.27B $0.35B 15.45%
2023-09-30 $2.23B $0.32B 14.20%
2023-06-30 $2.19B $0.30B 13.67%
2023-03-31 $2.16B $0.32B 14.56%
2022-12-31 $2.14B $0.33B 15.41%
2022-09-30 $2.13B $0.34B 16.11%
2022-06-30 $2.14B $0.36B 16.90%
2022-03-31 $2.14B $0.35B 16.38%
2021-12-31 $2.14B $0.35B 16.36%
2021-09-30 $2.13B $0.40B 18.77%
2021-06-30 $2.12B $0.39B 18.25%
2021-03-31 $2.09B $0.41B 19.71%
2020-12-31 $2.08B $0.40B 19.10%
2020-09-30 $2.07B $0.33B 16.01%
2020-06-30 $2.02B $0.32B 15.64%
2020-03-31 $1.99B $0.28B 14.05%
2019-12-31 $1.94B $0.26B 13.51%
2019-09-30 $1.88B $0.25B 13.07%
2019-06-30 $1.84B $0.24B 13.11%
2019-03-31 $1.81B $0.24B 13.01%
2018-12-31 $1.78B $0.24B 13.46%
2018-09-30 $1.75B $0.24B 13.41%
2018-06-30 $1.73B $0.23B 13.09%
2018-03-31 $1.70B $0.13B 7.65%
2017-12-31 $1.67B $0.12B 7.02%
2017-09-30 $1.64B $0.11B 6.76%
2017-06-30 $1.62B $0.10B 6.18%
2017-03-31 $1.59B $0.18B 11.24%
2016-12-31 $1.58B $0.18B 11.23%
2016-09-30 $1.57B $0.17B 11.07%
2016-06-30 $1.57B $0.18B 11.37%
2016-03-31 $1.56B $0.18B 11.62%
2015-12-31 $1.54B $0.18B 11.66%
2015-09-30 $1.52B $0.18B 11.81%
2015-06-30 $1.50B $0.17B 11.56%
2015-03-31 $1.47B $0.17B 11.47%
2014-12-31 $1.46B $0.16B 11.20%
2014-09-30 $1.43B $0.15B 10.67%
2014-06-30 $1.41B $0.14B 9.80%
2014-03-31 $1.41B $0.12B 8.68%
2013-12-31 $1.41B $0.12B 8.77%
2013-09-30 $1.43B $0.13B 9.00%
2013-06-30 $1.45B $0.14B 9.47%
2013-03-31 $1.44B $0.15B 10.25%
2012-12-31 $1.43B $0.15B 10.14%
2012-09-30 $1.41B $0.14B 10.21%
2012-06-30 $1.40B $0.15B 10.44%
2012-03-31 $1.38B $0.14B 10.46%
2011-12-31 $1.36B $0.14B 10.33%
2011-09-30 $1.34B $0.14B 10.07%
2011-06-30 $1.32B $0.13B 10.08%
2011-03-31 $1.30B $0.13B 10.06%
2010-12-31 $1.28B $0.13B 10.47%
2010-09-30 $1.25B $0.13B 10.10%
2010-06-30 $1.22B $0.12B 10.13%
2010-03-31 $1.20B $0.12B 10.05%
2009-12-31 $1.19B $0.12B 10.17%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.076B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.002B 10.28
Quest Diagnostics (DGX) United States $15.353B 15.87
DaVita (DVA) United States $12.299B 15.28
Elanco Animal Health (ELAN) United States $8.994B 23.33
Encompass Health (EHC) United States $8.506B 21.77
Option Care Health (OPCH) United States $4.839B 18.32
RadNet (RDNT) United States $4.232B 88.12
Amedisys (AMED) United States $2.993B 21.20
Astrana Health (ASTH) United States $2.272B 30.72
LifeStance Health (LFST) United States $2.018B 0.00
Addus HomeCare (ADUS) United States $1.914B 27.38
U.S Physical Therapy (USPH) United States $1.400B 37.46
Pennant (PNTG) United States $0.662B 34.98
Aveanna Healthcare Holdings (AVAH) United States $0.491B 0.00
Atai Life Sciences (ATAI) Germany $0.223B 0.00
Daxor (DXR) United States $0.042B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.014B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00